Genetically Engineered Biologic Drugs in Management of Children with Bronchial Asthma
Current article represents the modern clinical guidelines on management of severe bronchial asthma (BA) in children and practical use of genetically engineered biologic drugs. Clinical efficacy and safety of omalizumab has its special role. Efficacy analysis was carried out in real-life' clinic...
Saved in:
| Main Authors: | Svetlana V. Zaytseva, Anna U. Tomilova, Olga V. Zaytseva, Olga B. Voronina, Olga A. Murtazaeva, Valeriy A. Mukhortykh, Irina N. Tsymbal |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2021-12-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/2071 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRIMARY RESULTS OF LONG-TERM DYNAMIC MONITORING OF CHILDREN WITH BRONCHIAL ASTHMA OF UNCONTROLLED SEVERE PERSISTENT COURSE
by: L. S. Namazova-Baranova, et al.
Published: (2017-02-01) -
ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021-08-01) -
Pilot Project «All-Russian Registry of Patients with Severe Bronchial Asthma.» The First Results in a Children’s Group of Patients (Moscow’s Observation Program)
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-08-01) -
Modern Understanding of Severe Bronchial Asthma
by: A. Yu. Kraposhina, et al.
Published: (2022-03-01) -
PEDIATRIC BRONCHIAL ASTHMA: MODERN TREATMENT ASPECTS
by: O.V. Zaitseva, et al.
Published: (2011-11-01)